Gemcitabine gemzar
Gemcitabine (GEMZAR) is a laboratory reagent manufactured by Eli Lilly. It is a pyrimidine nucleoside analog used for research purposes.
Lab products found in correlation
10 protocols using gemcitabine gemzar
Isolation and Culture of Primary Cells
Erlotinib and Gemcitabine Preparation
Cell Culture and Drug Treatments
Lung Cancer Cell Line Characterization
Combination Therapy for Pancreatic Cancer
Consequently, for BxPC-3 cells, the mice were divided into 7 experimental treatment groups: placebo (P), Gemcitabin (G), Everolimus (E), Gemcitabin + Everolimus (G+E), Gemcitabin + Zoledronic Acid (G + AZ), Everolimus + Zoledronic Acid (E+AZ) and Gemcitabin + Everolimus + Zoledronic Acid (G+E+AZ). For Panc-1 cells, the mice were randomized into only 4 experimental treatment groups: placebo (P), Gemcitabin (G), Everolimus + Zoledronic Acid (E+AZ) and Gemcitabin + Everolimus + Zoledronic Acid (G+E+AZ).
Gemcitabine (GEMZAR, Eli Lilly, France) was administered by peritoneal injection (PI), twice a week at 100 mg/kg of body weight. Zoledronic Acid (Zometa®, Novartis Pharma, France) was administered once a week by PI at 100μg/kg of body weight, and Everolimus (Afinitor®, Novartis Pharma, France) was administered by gavage at 3 mg/kg of body weight. Treatments were provided and prepared by the pharmacy of Angers University Hospital. Control animals in placebo groups received an equal volume of saline solution to the active molecule [32 (link), 33 (link)].
Cell Culture Conditions for Gallbladder Cancer
Colorectal Cancer Cell Line Cultivation and Compound Sourcing
Synthesis of SW IV-134 and Gemcitabine
Oridonin Potentiates Gemcitabine-Induced Apoptosis in Pancreatic Cancer
Evaluation of Anticancer Drug Combinations
About the other chemicals—thapsigargin, puromycin, anisomycin, ionomycin, Hyp9, OAG, U73343, and Wortmannin—were from Sigma-Aldrich. BMS-754807 and PD98059 were purchased from Selleckchem. Larixyl acetate was obtained from Santa Cruz Biotechnology (Dallas, TX, USA). Pyr3 was from Calbiochem (Merck Millipore, Darmstadt, Germany). Human IGF1 was from Miltenyi Biotec (Paris, France). QVD-OPh was purchased from R&D Systems (Minneapolis, MN, USA).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!